Luke O'Neill: Double trouble or the future of health care - are you ready to meet your digital twin?Digital twins could personalize healthcare using comprehensive data on individuals' genetics and health for applications like drug trials and surgical planning.
Amazing' trial shows drug combination stops lung cancer advancing for longerA new drug combination significantly extends progression-free survival in advanced lung cancer patients compared to standard treatment.
An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche's market valuePositive results in small trials for obesity drugs led to significant market value gains, driven by the large potential market size.